These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 33666764)
1. Drug Interactions with Antihypertensives. Fravel MA; Ernst M Curr Hypertens Rep; 2021 Mar; 23(3):14. PubMed ID: 33666764 [TBL] [Abstract][Full Text] [Related]
2. Issues in drug metabolism of major antihypertensive drugs: beta-blockers, calcium channel antagonists and angiotensin receptor blockers. Höcht C; Bertera FM; Mayer MA; Taira CA Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):199-211. PubMed ID: 20095790 [TBL] [Abstract][Full Text] [Related]
3. Cochrane in context: pharmacological interventions for hypertension in children. Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological interventions for hypertension in children. Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305 [TBL] [Abstract][Full Text] [Related]
5. Interactions between antipsychotic and antihypertensive drugs. Markowitz JS; Wells BG; Carson WH Ann Pharmacother; 1995 Jun; 29(6):603-9. PubMed ID: 7663034 [TBL] [Abstract][Full Text] [Related]
6. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension. Thomas GN; Chan P; Tomlinson B Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636 [TBL] [Abstract][Full Text] [Related]
7. Intriguing relationship between antihypertensive therapy and cancer. Tadic M; Cuspidi C; Belyavskiy E; Grassi G Pharmacol Res; 2019 Mar; 141():501-511. PubMed ID: 30682424 [TBL] [Abstract][Full Text] [Related]
8. Antihypertensive drug prescription trends at the primary health care centres in Bahrain. Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335 [TBL] [Abstract][Full Text] [Related]
9. Factors influencing hepatic metabolism of antihypertensive drugs: impact on clinical response. Höcht C; Bertera FM; Santander Plantamura Y; Parola L; Del Mauro JS; Polizio AH Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):1-13. PubMed ID: 30582386 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive therapy: special focus on drug interactions. Maas R; Böger RH Expert Opin Drug Saf; 2003 Nov; 2(6):549-79. PubMed ID: 14585065 [TBL] [Abstract][Full Text] [Related]
11. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff. Epstein BJ; Anderson S Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086 [TBL] [Abstract][Full Text] [Related]
12. Effect of HMG-CoA reductase inhibitors on blood pressure in hypertensive patients treated with blood pressure-lowering agents: retrospective study using an anti-hypertensive drug database. Hashimoto S; Urushihara H; Hinotsu S; Kosugi S; Kawakami K Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):235-41. PubMed ID: 22428476 [TBL] [Abstract][Full Text] [Related]
13. [Influence of rifampicin on antihypertensive effects of dihydropiridine calcium-channel blockers in four elderly patients]. Yoshimoto H; Takahashi M; Saima S Nihon Ronen Igakkai Zasshi; 1996 Sep; 33(9):692-6. PubMed ID: 8940868 [TBL] [Abstract][Full Text] [Related]
14. Antihypertensive drug interactions. Carter BL Drugs Today (Barc); 2005 Jan; 41(1):55-63. PubMed ID: 15753969 [TBL] [Abstract][Full Text] [Related]
15. Implications of cytochrome P450 interactions when prescribing medication for hypertension. Flockhart DA; Tanus-Santos JE Arch Intern Med; 2002 Feb; 162(4):405-12. PubMed ID: 11863472 [TBL] [Abstract][Full Text] [Related]
16. Use of calcium channel blockers in hypertension. Conlin PR; Williams GH Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192 [TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-inflammatory drugs and antihypertensives. Houston MC Am J Med; 1991 May; 90(5A):42S-47S. PubMed ID: 1903902 [TBL] [Abstract][Full Text] [Related]
18. Polypharmacy and medication usage patterns in hypertensive patients: Findings from the Pars Cohort Study. Zare P; Poustchi H; Mohammadi Z; Mesgarpour B; Akbari M; Kamalipour A; Abdipour-Mehrian SR; Hashemi ES; Ghamar-Shooshtari A; Hosseini SA; Malekzadeh R; Bazrafshan Drissi H; Malekzadeh F; Molavi Vardanjani H Res Social Adm Pharm; 2024 Nov; 20(11):1038-1046. PubMed ID: 39098543 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis. Van Bortel LM; Fici F; Mascagni F Am J Cardiovasc Drugs; 2008; 8(1):35-44. PubMed ID: 18303936 [TBL] [Abstract][Full Text] [Related]
20. Drug-drug interactions involving antipsychotics and antihypertensives. Buzea CA; Dima L; Correll CU; Manu P Expert Opin Drug Metab Toxicol; 2022 Apr; 18(4):285-298. PubMed ID: 35658798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]